Suppr超能文献

结直肠癌患者肿瘤定位和血脂参数与生存的关系

Relationship of Tumor Localization and Lipid Parameters with Survival in Patients with Colorectal Cancer.

作者信息

Sever Özlem Nuray, Başoğlu Tuğba, Yıldırım Sedat

机构信息

Department of Medical Oncology, Medical Park Bahcelievler Hospital, Istanbul 34180, Türkiye.

Department of Medical Oncology, Health Science University, Kartal Dr. Lütfi Kirdar City Hospital, Istanbul 34865, Türkiye.

出版信息

J Clin Med. 2025 Feb 15;14(4):1302. doi: 10.3390/jcm14041302.

Abstract

: Colorectal cancer (CRC) remains a global health challenge. Metabolic disorders, including dyslipidemia, have been linked to CRC progression, yet the relationship between lipid profiles, tumor location, and survival outcomes remains controversial. This study investigates the association between blood lipid parameters, tumor localization, and survival in CRC patients. : A retrospective analysis was conducted on 126 CRC patients diagnosed between 2017 and 2024 at Kartal Dr. Lütfi Kırdar City Hospital. Patients with comorbidities affecting lipid metabolism or who were on lipid-lowering drugs were excluded. Clinical, pathological, and lipid data, including total cholesterol (TC), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and carcinoembryonic antigen (CEA), were analyzed. Tumor location was categorized as right-sided or left-sided. Overall survival (OS) was evaluated with a statistical analysis using Kaplan-Meier and Cox regression models. : Higher HDL-C levels and a lower TC/HDL-C ratio were significantly associated with improved OS (: 0.004 and : 0.016, respectively). This relationship remained significant in early- and advanced-stage disease (: 0.04 for HDL-C and : 0.03 for TC/HDL-C). In patients with tumors located in the right colon, LDL-C levels of 150 mg/dL and below were found to be statistically positively correlated with overall survival, while in patients with tumors located in the left colon, HDL-C levels of 45 mg/dL and above and TC/HDL-C levels of 4.16 and above were found to be statistically positively correlated with overall survival. A multivariate analysis confirmed that age, stage, HDL-C, and TC/HDL-C were independent predictors of OS. : Our study highlights the potential role of lipid profiles, particularly HDL-C and the TC/HDL-C ratio, as prognostic factors in CRC. Further research, including molecular and genetic analyses, is needed to better understand the mechanisms underlying the relationship between lipid metabolism and CRC progression.

摘要

结直肠癌(CRC)仍然是一项全球性的健康挑战。包括血脂异常在内的代谢紊乱与CRC进展有关,但血脂水平、肿瘤位置和生存结果之间的关系仍存在争议。本研究调查了CRC患者血脂参数、肿瘤定位与生存之间的关联。:对2017年至2024年期间在卡尔塔尔·吕特菲·基尔达尔市立医院诊断的126例CRC患者进行了回顾性分析。排除患有影响脂质代谢的合并症或正在服用降脂药物的患者。分析了临床、病理和血脂数据,包括总胆固醇(TC)、甘油三酯(TGs)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和癌胚抗原(CEA)。肿瘤位置分为右侧或左侧。使用Kaplan-Meier和Cox回归模型进行统计分析评估总生存期(OS)。:较高的HDL-C水平和较低的TC/HDL-C比值与改善的OS显著相关(分别为P = 0.004和P = 0.016)。这种关系在早期和晚期疾病中仍然显著(HDL-C为P = 0.04,TC/HDL-C为P = 0.03)。在右半结肠癌患者中,发现LDL-C水平低于150 mg/dL与总生存期呈统计学正相关,而在左半结肠癌患者中,发现HDL-C水平高于45 mg/dL和TC/HDL-C水平高于4.16与总生存期呈统计学正相关。多变量分析证实年龄、分期、HDL-C和TC/HDL-C是OS的独立预测因素。:我们的研究强调了血脂水平,特别是HDL-C和TC/HDL-C比值,作为CRC预后因素的潜在作用。需要进一步的研究,包括分子和基因分析,以更好地理解脂质代谢与CRC进展之间关系的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/533f/11856523/0b3d5fd55a4b/jcm-14-01302-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验